Cartesian Therapeutics Inc (RNAC)
Net Income Growth
-13.63%
Quarterly · Period ending:
RNAC Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-13.63%period ending
Latest reported-13.63%period ending
RNAC Quarterly Net Income YoY % (-30.40% → -13.63%)
Year-over-year change
High-resolution chart · PNG
RNAC net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -13.6346% | |
| -121.2422% | |
| -802.9162% | |
| -48.4597% | |
| 14.8164% | |
| 68.8336% | |
| 94.2288% | |
| -168.6403% | |
| 221.507% | |
| -162.309% | |
| -3,114.7293% | |
| -14.0504% | |
| -232.3916% | |
| -175.2763% | |
| -51.8506% | |
| 55.8902% | |
| 88.4118% | |
| 216.998% | |
| 179.2373% | |
| -83.9243% | |
| 118.9569% | |
| -25.367% | |
| -3.748% | |
| 18.8844% | |
| -46.8891% | |
| -62.4979% | |
| -1.6176% | |
| 25.0422% | |
| 12.7793% | |
| 24.0055% | |
| 25.0358% | |
| -9.0283% | |
| -17.7178% | |
| -4.9822% | |
| -38.7772% | |
| -89.9068% | |
| -130.637% | |
| -102.4345% | |
| -105.6213% | |
| -34.9869% | |
| -0.8155% | |
| -30.4029% |